Apoptosis overrides survival signals through a caspase-mediated dominant-negative NF-κB loop

Nature Cell Biology

Volumn 1, Issue 4, 1999, Pages 227-233

  Levkau, Bodo ^a,b   Scatena, Marta ^a   Giachelli, Cecilia M ^a   Ross, Russell ^a   Raines, Elaine W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PRIMER DNA; TRANSCRIPTION FACTOR RELA;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; BINDING SITE; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CYTOLOGY; ENZYME ACTIVATION; ENZYME SPECIFICITY; FEEDBACK SYSTEM; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; BINDING SITES; CASPASES; CELL SURVIVAL; CELLS, CULTURED; DNA PRIMERS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; FEEDBACK; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NF-KAPPA B; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC;

EID: 0033174072     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/12050     Document Type: Article

References (39)

1. Baeuerle, P. A. & Baltimore, D. NF-κB: Ten years after. Cell 87, 15-20 (1996).
2. Baeuerle, P. A. & Henkel, T. Function and activation of NF-ΚB in the immune system. Annu. Rev. Immunol. 12, 141-179 (1994).
3. Baldwin, A.S. Jr The NF-ΚB and 1ΚB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-483 (1996).
4. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. & Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-ΚB. Nature 376, 167-170 (1995).
5. Beg, A. A. & Baltimore, D. An essential role for NF-ΚB in preventing TNF-α-induced cell death. Science 274, 782-784 (1996).
6. Liu, Z. G., Hsu, H., Goeddel, D. V., & Karin, M. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-αB activation prevents cell death. Cell 87, 565-576 (1996).
7. Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R. & Verma, I. M. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274, 787-789 (1996).
8. Wang, C. Y., Mayo, M. W. & Baldwin, A. S. Jr TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274, 784-787 (1996).
9. Sovak, M. A. et al. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer. J. Clin. Invest. 100, 2952-2960 (1997).
10. Bargou, R. C. et al. Constitutive nuclear factor-kappa B-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest. 100, 2961-2969 (1997).
11. 3 integrin-induced endothelial cell survival. J. Cell Biol. 141, 1083-1093 (1998).
12. Palombella, V. J., Rando, O. J., Goldberg, A. L. & Maniatis, T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78, 773-785 (1994).
13. Maniatis, T. Catalysis by a multiprotein IκB kinase complex. Science 278, 818-819 (1997).
14. Stancovski, I. & Baltimore, D. NF-κB activation: the IκB kinase revealed? Cell 91, 299-302 (1997).
15. Gerritsen, M. E. et al. CREB-binding protein/p300 are transcriptional coactivatorsof p65. Proc. Natl Acad. Sci. USA 94, 2927-2932 (1997).
16. Zhong, H., Voll, R. E. & Ghosh, S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactlvator CBP/p300. Mol. Cell 1, 661-671 (1998).
17. Perkins, N. D. et al. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523-527 (1997).
18. Meikrantz, W. &Schlegel, R. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J. Biol. Chem. 271, 10205-10209 (1996).
19. Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol. Cell 1, 553-563 (1998).
20. Salvesen, G. S. & Dixit, V. M. Caspases: intracellular signaling by proteolysis. Cell 91, 443-446 (1997).
21. FAK and disassembly of focal adhesions in human endothelial cell apoptosis. J. Exp. Med. 187, 579-586 (1998).
22. Talanian, R. V. et al. Substrate specificities of caspase family proteases. J. Biol. Chem. 272, 9677-9682 (1997).
23. Thornberry, N. A. Caspases: key mediators of apoptosis. Chem. Biol. 5, R97-R103 (1998).
24. Schmitz, M. L. et al. Structural and functional analysis of the NF-κB p65 C terminus. An acidic and modular transactivation domain with the potential to adopt an alpha-helical conformation. J. Biol. Chem. 269, 25613-25620 (1994).
25. Grimm, S., Bauer, M. K., Baeuerle, P. A. & Schulze Osthoff, K. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell Biol. 134, 13-23 (1996).
26. Karsan, A., Yee, E. & Harlan, J. M. Endothelial cell death induced by tumor necrosis factor-α is inhibited by the Bcl-2 family member A1. J. Biol. Chem. 271, 27201-27204 (1996).
27. Grilli, M., Goffi, F., Memo, M. & Spano, P. Interleukin-1β and glutamate activate the NF-κB/Rel binding site from the regulatory region of the amyloid precursor protein gene in primary neuronal cultures. J. Biol. Chem. 271, 15002-15007 (1996).
28. Baichwal, V. R. & Baeuerle, P. A. Activate NF-κB or die? Curr. Biol. 7, R94-R96 (1997).
29. Mandal, M. et al. Bcl-2 prevents CD95 (Fas/APO-1)-induced degradation of lamin B and poly( ADPribose) polymerase and restores the NF-κB signaling pathway. J. Biol. Chem. 271, 30354-30359 (1996).
30. Ponton, A., Cl'ement, M. V. & Stamenkovic, I. The CD95 (APO-1/Fas) receptor activates NF-KB independently of its cytotoxic function. J. Biol. Chem. 271, 8991-8995 (1996).
31. Rensing Ehl, A. et al. Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo. Eur. J. Immunol. 25, 2253-2258 (1995).
32. Schulze Osthoff, K., Krammer, P. H. & Droge, W. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 13, 4587-4596 (1994).
33. Ravi, R., Bedi, A., Fuchs, E. J. & Bedi, A. CD95 (Fas)-induced caspase-media ted proteolysis of NF-κB. Cancer Res. 58, 882-886 (1998).
34. Cheng, E. H. et al. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278, 1966-1968 (1997).
35. Barkett, M., Xue, D., Horvitz, H. R. & Gilmore, T. D. Phosphorylation of IκB-α inhibits its cleavage by caspase CPP32 in vitro. J. Biol. Chem. 272, 29419-29422 (1997).
36. Thanos, D. & Maniatis, T. NF-κB: a lesson in family values. Cell 80, 529-532 (1995).
37. Qwarnstrom, E. E., Ostberg, C. O., Turk, G. L., Richardson, C. A. & Bomsztyk, K. Fibronectin attachment activates the NF-κB p50/p65 heterodimer in fibroblasts and smooth muscle cells. J. Biol. Chem. 269, 30765-30768 (1994).
38. Guo, X., Zhang, Y. P., Mitchell, D. A., Denhardt, D. T. & Chambers, A. F. Identification of a rasactivated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell. Mol. Cell. Biol. 15, 476-487 (1995).
39. Lee, K. A., Bindereif, A. & Green, M. R. A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene. Anal. Tech. 5, 22-31 (1988).